Skip to main content

Mills Kenneth T.'s Form 4 filing

REGENXBIO Inc.RGNX · filed Sep 15, 2021

Accession no.
0001562180-21-005947
Filed
Sep 15, 2021
Trade date
Sep 13-14, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 5 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.70M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Mills Kenneth T.CIK 0001652824Director, Officer (President and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 13, 2021Common StockMOption exerciseAcquired+3,000$3.76+$11,280283,984Direct
Sep 13, 2021Common StockSSaleDisposed−3,000$40.02−$120,060280,984Direct
Sep 14, 2021Common StockMOption exerciseAcquired+33,146$3.76+$124,628.96314,130Direct
Sep 14, 2021Common StockMOption exerciseAcquired+1,854$0.85+$1,575.9315,984Direct
Sep 14, 2021Common StockSSaleDisposed−35,000$45.11F2−$1,578,850280,984Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 13, 2021Common StockMOption exerciseDisposed−3,000$0.00$0266,000Direct
Sep 14, 2021Common StockMOption exerciseDisposed−33,146$0.00$0232,854Direct
Sep 14, 2021Common StockMOption exerciseDisposed−1,854$0.00$037,816Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at prices ranging from $45.00 to $45.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)